Mather Group LLC. Has $99,000 Stock Position in Chemed Corporation (NYSE:CHE)

Mather Group LLC. raised its holdings in Chemed Corporation (NYSE:CHE) by 53.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 161 shares of the company’s stock after acquiring an additional 56 shares during the quarter. Mather Group LLC.’s holdings in Chemed were worth $99,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new stake in shares of Chemed in the 4th quarter valued at $42,023,000. Bessemer Group Inc. boosted its stake in shares of Chemed by 14.2% in the 1st quarter. Bessemer Group Inc. now owns 950 shares of the company’s stock valued at $585,000 after purchasing an additional 118 shares during the last quarter. Park Place Capital Corp boosted its stake in shares of Chemed by 71.2% in the 1st quarter. Park Place Capital Corp now owns 3,572 shares of the company’s stock valued at $2,198,000 after purchasing an additional 1,486 shares during the last quarter. Synergy Asset Management LLC boosted its stake in shares of Chemed by 108.4% in the 1st quarter. Synergy Asset Management LLC now owns 3,049 shares of the company’s stock valued at $1,876,000 after purchasing an additional 1,586 shares during the last quarter. Finally, Silver Oak Securities Incorporated bought a new stake in shares of Chemed in the 1st quarter valued at $309,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Saturday. Bank of America cut their target price on shares of Chemed from $708.00 to $650.00 and set a “buy” rating on the stock in a research note on Monday, June 30th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $640.00 target price (down from $674.00) on shares of Chemed in a research note on Monday, June 30th.

Chemed Stock Up 0.3%

Shares of NYSE CHE opened at $472.61 on Friday. The firm has a market cap of $6.91 billion, a PE ratio of 23.02, a P/E/G ratio of 2.28 and a beta of 0.50. Chemed Corporation has a 12-month low of $469.80 and a 12-month high of $623.61. The company’s fifty day simple moving average is $555.54 and its 200 day simple moving average is $562.88.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a net margin of 12.40% and a return on equity of 27.58%. Chemed’s revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.20 earnings per share. On average, equities analysts predict that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were issued a dividend of $0.50 per share. The ex-dividend date was Thursday, May 29th. This represents a $2.00 annualized dividend and a yield of 0.42%. Chemed’s payout ratio is 9.74%.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the company’s stock in a transaction on Monday, May 5th. The shares were sold at an average price of $576.45, for a total transaction of $864,675.00. Following the transaction, the chief executive officer owned 101,197 shares in the company, valued at approximately $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 1,500 shares of the company’s stock in a transaction on Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the transaction, the executive vice president owned 14,627 shares in the company, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,500 shares of company stock worth $2,598,450. Corporate insiders own 3.29% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.